Snapshot

DOI:

EuroIntervention: focussing on clinical practice through the latest data and techniques such as managing pulmonary embolisms, antithrombotic monotherapy, CAS- and CEA-related outcomes and more

There is always a lot going on in our field – and just keeping up with the latest research can sometimes seem like a full-time job. We are here to help, and that’s why we often provide you with state-of-the-art and expert reviews as well as touching on a vast range of topics, for instance, in this issue, from outcomes in carotid artery interventions to an interesting approach to using crushed prasugrel in STEMI patients and much more. Read on, and I am sure you will find something of interest!

Percutaneous treatment of pulmonary embolism

Simone Finocchiaro, Davide Capodanno and colleagues offer a state-of-the-art review of emerging percutaneous interventional procedures for pulmonary embolism, including catheter-directed thrombolysis and mechanical thrombectomy, providing guidance on the selection of patients and the appropriate treatments.

See page e408

Efficacy of antithrombotic monotherapy according to revascularisation

Takashi Noda, Satoshi Yasuda and colleagues demonstrate that rivaroxaban monotherapy had favourable safety and efficacy outcomes over combination therapy in high thrombotic risk patients with a history of prior revascularisation in this post hoc analysis of the AFIRE trial.

See page e425

Crushed prasugrel loading dose in STEMI patients

Jeroen M. Wilschut, Roberto Diletti and colleagues investigate if patients with a large myocardial infarction benefit from prehospital administration of a crushed prasugrel loading dose. Improvements in postprocedural TIMI 3 flow after receiving the crushed loading dose led the authors to believe this may be a rapid and cost- effective strategy to improve myocardial perfusion.

See page e436

Comparison of carotid artery stenting- and carotid endarterectomy-related outcomes

Alberto Bramucci, Fausto Castriota and colleagues compare carotid endarterectomy and carotid artery stenting for the treatment of extracranial carotid artery stenosis. Carotid artery stenting has developed on both the surgical and endovascular fronts, and the authors find the 30-day outcomes for stroke, acute myocardial infarction, and death to be similar for both carotid artery stenting and carotid endarterectomy.

See page e445

Volume 20 Number 7
Apr 1, 2024
Volume 20 Number 7
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved